Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
The global antacids market will reach $10.5B in 2027, growing at a CAGR of 3.78% during 2022-2027, according to a report from Research & Markets.
read more
The global desiccants market will grow from $150M in 2022 to $160M in 2023 at a compound annual growth rate (CAGR) of 5.0%, according to Reportlinker.
read more
The Alzheimer’s disease market is forecast to grow by $3.99B between 2021 and 2026 at a CAGR of 8.76%, according to a report from Technavio.
read more
Quotient Sciences, a drug development and manufacturer, announced that it has completed an expansion of its early-phase formulation development capabilities for oral dosage forms at its Nottingham, UK, facility.
read more
Apotex Inc. is recalling one lot of APO-Amitriptyline 10 mg tablets due to the presence of N-nitrosodimethylamine (NDMA), a nitrosamine impurity, above the acceptable limit. Patients should continue taking their amitriptyline drug, as the risks from not having adequate treatment outweigh possible effects of exposure to the levels of NDMA seen in ...
read more
Upsher-Smith, a Midwest-based pharmaceutical company focused on specialty brands and generics, announced the opening of its new, 270,000 square-foot manufacturing facility in Maple Grove, Minnesota. The facility offers up-to-date packaging and serialization capabilities and supports contract manufacturing for third parties.
read more
The personalized nutrition market is anticipated to grow at a CAGR of 16.61% during 2022-2028., according to a report from Arizton.
read more
Supplements targeting skin health are booming, with more than 30% average annual growth in product launches of dietary supplements globally between 2017 and 2021, according to a report from Innova Market Insights.
read more
KORSCH AG, tablet press manufacturer, has announced the acquisition of MEDELPHARM,a provider of compaction simulator technology.
read more
The global antipsychotic drugs market will expand by a 7 CAGR by 2027, due to the increasing prevalence of mental disorders such as schizophrenia, schizoaffective disorder, bipolar disorder, severe depression, psychotic symptoms of a personality disorder, and others, according to a report by DelveInsight.
read more
The global rheumatoid arthritis drugs market is estimated to grow annually at a CAGR of around 1.75% over the forecast period (2022-2030). In terms of revenue, the global rheumatoid arthritis drugs market size was valued at around $60.1B in 2021 and is projected to reach $70.1B by 2030, according to a report by Facts and Factors.
read more
The global empty capsules market size was valued at $2.52B in 2021 and is projected to reach $4.64B by 2030, growing at a CAGR of 7.00% from 2023 to 2030, according to a report from Verified Market Research®,
read more
The U.S. Food and Drug Administration approved Jesduvroq tablets (daprodustat) as the first oral treatment for anemia (decreased number of red blood cells) caused by chronic kidney disease for adults who have been receiving dialysis for at least four months. Jesduvroq is not approved for patients who are not on dialysis. Other FDA-approved ...
read more
ACG, supplier of pharmaceutical and nutraceutical manufacturing products, announced the appointment of Rafael Costa as Vice President for the Americas region.
read more
The global nutraceutical excipients market is expected to reach the value of $3,685.86M by 2030, at a CAGR of 7.4% during the forecast period, according to a report from Data Bridge Market Research.
read more